Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Moczygemba

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
The Health Care Manager|June 20, 2001
Managing clinical data in an electronic environmentJ Moczygemba, B Hewitt
Journal of AHIMA|September 30, 2000
MPIs (master patient index) in healthcare: current trends and practicesJ Moczygemba, S Biedermann
Journal of AHIMA|February 24, 2001
Creating a diverse HIM work forceJ Moczygemba, R B Welborn
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 4, 2001
A phase I and pharmacologic study of capecitabine and paclitaxel in breast cancer patientsM A Villalona-Calero, J L Blum, S E Jones, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Phase I and pharmacokinetic study of the oral fluoropyrimidine capecitabine in combination with paclitaxel in patients with advanced solid malignanciesM A Villalona-Calero, G R Weiss, H A Burris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2000
Phase I and pharmacokinetic study of irofulven, a novel mushroom-derived cytotoxin, administered for five consecutive days every four weeks in patients with advanced solid malignanciesS G Eckhardt, S D Baker, C D Britten, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Phase I and pharmacologic study of the tyrosine kinase inhibitor SU101 in patients with advanced solid tumorsS G Eckhardt, J Rizzo, K R Sweeney, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
The Health Care Manager|June 20, 2001
Managing clinical data in an electronic environmentJ Moczygemba, B Hewitt
Journal of AHIMA|September 30, 2000
MPIs (master patient index) in healthcare: current trends and practicesJ Moczygemba, S Biedermann
Journal of AHIMA|February 24, 2001
Creating a diverse HIM work forceJ Moczygemba, R B Welborn
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 4, 2001
A phase I and pharmacologic study of capecitabine and paclitaxel in breast cancer patientsM A Villalona-Calero, J L Blum, S E Jones, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Phase I and pharmacokinetic study of the oral fluoropyrimidine capecitabine in combination with paclitaxel in patients with advanced solid malignanciesM A Villalona-Calero, G R Weiss, H A Burris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2000
Phase I and pharmacokinetic study of irofulven, a novel mushroom-derived cytotoxin, administered for five consecutive days every four weeks in patients with advanced solid malignanciesS G Eckhardt, S D Baker, C D Britten, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Phase I and pharmacologic study of the tyrosine kinase inhibitor SU101 in patients with advanced solid tumorsS G Eckhardt, J Rizzo, K R Sweeney, et al.
Pageof 1